These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 9504186

  • 21. Mechanism underlying the inhibitory effect of dexamethasone on in vivo erythropoiesis.
    Giglio MJ, Alippi RM, Bozzini CE.
    Exp Hematol; 1980 Aug; 8(7):911-6. PubMed ID: 16398023
    [Abstract] [Full Text] [Related]

  • 22. Effects of terbutaline, a synthetic beta adrenoceptor agonist, on in vivo erythropoietin production.
    Gross DM, Fisher JW.
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):192-201. PubMed ID: 34369
    [Abstract] [Full Text] [Related]

  • 23. Reduced extrarenal erythropoietin production in rats treated with isoproterenol.
    Zangheri EO.
    Exp Hematol; 1977 May; 5(3):211-4. PubMed ID: 872909
    [Abstract] [Full Text] [Related]

  • 24. Decreased adrenergic sensitivity in patients with hypothyroidism.
    Polikar R, Kennedy B, Maisel A, Ziegler M, Smith J, Dittrich H, Nicod P.
    J Am Coll Cardiol; 1990 Jan; 15(1):94-8. PubMed ID: 1967261
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Sex differences in sensitivity to beta-adrenergic agonist isoproterenol in the isolated adult rat heart following prenatal protein restriction.
    Elmes MJ, Haase A, Gardner DS, Langley-Evans SC.
    Br J Nutr; 2009 Mar; 101(5):725-34. PubMed ID: 18590591
    [Abstract] [Full Text] [Related]

  • 27. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL, Blaak EE, Saris WH, van Baak MA.
    Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
    [Abstract] [Full Text] [Related]

  • 28. Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.
    Fletcher DS, Candelore MR, Grujic D, Lowell BB, Luell S, Susulic VS, Macintyre DE.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):720-4. PubMed ID: 9808702
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Beta-adrenergic stimulation of volume-sensitive chloride transport in lamprey erythrocytes.
    Nikinmaa M, Salama A, Bogdanova A, Virkki LV.
    Physiol Biochem Zool; 2001 Nov; 74(1):45-51. PubMed ID: 11226013
    [Abstract] [Full Text] [Related]

  • 32. Reduced beta-adrenergic responsiveness in hypothyroid rats.
    Fregly MJ, Nelson EL, Resch GE, Field FP, Lutherer LO.
    Am J Physiol; 1975 Oct; 229(4):916-24. PubMed ID: 53017
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Molecular insight into the effects of hypothyroidism on the developing cerebellum.
    Dong H, Wade M, Williams A, Lee A, Douglas GR, Yauk C.
    Biochem Biophys Res Commun; 2005 May 20; 330(4):1182-93. PubMed ID: 15823568
    [Abstract] [Full Text] [Related]

  • 35. [Adrenergic receptor and knockout mouse: 1) Beta adrenergic receptor knockout mouse].
    Mizobe T.
    Masui; 2000 Dec 20; 49(12):1349-57. PubMed ID: 11193510
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Permanent effects of postnatal administration of beta-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats.
    Izdebska-Straszak G, Gubala E, Jedrzejowska-Szypulka H, Klencki M, Wiczkowski A, Jarzab B.
    Neuro Endocrinol Lett; 2006 Dec 20; 27(1-2):105-13. PubMed ID: 16648786
    [Abstract] [Full Text] [Related]

  • 39. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO, Derkach KV, Uspenskaia ZI, Shpakova EA, Kuznetsova LA, Plesneva SA, Pertseva MN.
    Tsitologiia; 2004 Dec 20; 46(4):317-25. PubMed ID: 15346790
    [Abstract] [Full Text] [Related]

  • 40. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.
    Thawani N, Tam M, Chang KH, Stevenson MM.
    Exp Hematol; 2006 Nov 20; 34(11):1451-61. PubMed ID: 17046564
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.